SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 24, 2020-- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the Cowen 40 th Annual Health Care Conference on Monday, March 2, 2020 at 11:10 am PT / 2:10 pm ET . Geoff Parker , Tricida’s Chief Financial Officer, will provide a

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 19, 2020-- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jan. 7, 2020-- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 38 th Annual J. P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 9:30 am PT / 12:30 pm ET . Gerrit Klaerner , Ph.D., Tricida’s Founder, Chief